U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"Everyone acquainted with the subject will recognize it as a conspicuous failure."

Henry Morton, president of the Stevens Institute of Technology ; Said in 1880 about the light bulb

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 549/200 - Oxygen containing hetero ring (e.g., dioxirane, etc.)


Subclass of Class 549 - Organic compounds -- part of the class 532-570 series
Definition: Compounds under Class 540, ... which contain a hetero ring
No. of patents: 120
Last issue date: 10/07/2008


1      
NumberTitleIssue Date
7432284Estrogen receptor modulators
The present invention relates to compounds and derivatives thereof, their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen receptors and as such may be useful for treatment or prevention of a v...
10/07/2008
7423061Substitute thiophenes and uses thereof
This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical salts, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cancer. ...
09/09/2008
7417068EPreceptor antagonists
A compound of formula (I): or a salt, solvate and chemically protected form thereof, wherein one of R2 and R5 is: (i) H or an optionally substituted C1-4 a...
08/26/2008
7417029Prodrug of an ice inhibitor
This invention describes an ICE inhibitor prodrug (I) having good bioavailability Compound I is useful for treating IL-1 mediated diseases such as rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, ulcerativ...
08/26/2008
7402670Synthesis by chiral diamine-mediated asymmetric alkylation
Chiral synthesis from an achiral starting material by chiral diamine-mediated, such as sparteine-mediated, intermolecular asymmetric alkylation with a strained cyclic ether in the presence of a Lewis acid. ...
07/22/2008
74026882,2-Di-substituted 1alpha,25-dihydroxy-19-norvitamin D derivative
A novel 2,2-di-substituted 19-norvitamin D derivative. It is a compound represented by the general formula (I) wherein R1 and R2 are the same or different and each represents hydroxy and A represents hydrogen, or an unsubstituted linear or branched alkyl.
07/22/2008
7388118Amine 1,2- and 1,3-diol compounds
Disclosed are compounds of formula: and pharmaceutically acceptable salts and esters thereof, useful in treating and/or preventing Alzheimer's disease and other similar diseases, wherein RN, RC, R...
06/17/2008
7385081Terephthalic acid composition and process for the production thereof
Terephthalic acid is prepared by reacting a 2,5-furandicarboxylate with ethylene in the presence of a solvent to produce a bicyclic ether; and then dehydrating the bicyclic ether. The process of the present invention effectively produces terephthalic acid, while red...
06/10/2008
7371875Cytotoxic agents and methods of use
Disclosed are compounds that inhibit proteasomic activity in cells. Also disclosed are pharmaceutical compositions comprising such compounds as well as methods to treat conditions, particularly cell proliferative conditions, such as cancer and inflammatory condition...
05/13/2008
73686081-amido-3-(2-hydroxyphenoxy)-2-propanol derivatives and a process for preparing 2-amidomethyl-1,4-benzodioxane derivatives
An 1-amido-3-(2-hydroxyphenoxy)-2-propanol derivative represented by the following formula (1), wherein cycle A may have further 1 to 4 substituents, and said substituent means a substituent selected from the group consisti...
05/06/2008
7368475Furanose-type bicyclic carbohydrates with biological activity
The synthesis and study of biological activity of a series of new molecules with potential antimicrobial activity are described. The molecules are bicyclic carbohydrates, based on furanose sugars. Their antimicrobial activity against viruses is demonstrated, next to...
05/06/2008
7358275Internal 1,15-lactones of fluprostenol and related prostaglandin F2a analogs and their use in the treatment of glaucoma and intraocular hypertension
Novel derivatives of prostaglandin compounds of the F-series (PGF), specifically macrocyclic internal 1,15-lactones of fluprostenol and related PGF analogs, such as cloprostenol or latanoprost. The novel analogs can be formulated into ophthalmic solutions and topica...
04/15/2008
73549452-oxadiazolechromone derivatives
Novel compounds of the formula I in which R, X and n are as defined herein, are inhibitors of tyrosine kinase and can be employed for the treatment of tumours, for neuroprotection and for protection o...
04/08/2008
7351399Prodrugs for phosphorus-containing compounds
Prodrugs of formula I, their uses, their intermediates, and their method of manufacture are described: and pharmaceutically acceptable prodrugs and salts thereof. ...
04/01/2008
7351734Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors
The present invention relates to aminoindane derivatives having the formula I wherein X, Y, U, R1-2, R13-16 and R are as defined in the claims, or an acid addition salt thereof. The compounds of the invention posses the combined effect of serot...
04/01/2008
7345181Process for preparing prostaglandin derivatives and starting materials for the same
The present invention provides a process for preparing benzoprostacycline derivatives of formula (1), i.e. 5,6,7-trinor-4,8-inter-m-phenylene PGI2 derivatives, and vinyl tin compounds of formula (III) as starting materials for the same. ...
03/18/2008
73296343-Phenyl substituted 3-substituted-4ketolactams and ketolactones
The invention relates to novel 3-phenyl-substituted, 3-substituted 4-ketolactams and -lactones of the formula (I) in which Q, W, X, Y, A, B and G are as defined in the disclosure, to proc...
02/12/2008
7326796Fluorinated monomers, fluorinated polymers having polycyclic groups with fused 4-membered heterocyclic rings, useful as photoresists, and processes for microlithography
The present invention provides novel fluorine-containing copolymers which comprise at least one fluorinated olefin, at least one polycyclic ethylenically unsaturated monomer with a fused 4-membered heterocyclic ring and, optionally, other components. The copolymers ...
02/05/2008
7297168Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
Five-membered heteroaromatic keratin dyeing compounds with one, two, or three heteroatoms. This invention further relates to a composition for the oxidative dyeing of keratin fibers, comprising a medium suitable for dyeing and one or more 5-membered heteroaromatic k...
11/20/2007
7271130N-alkynyl-2-(substituted phenoxy) alkylamides and their use as fungicides
Fungicidal compounds of the general formula (1) wherein X, Y, Z, R1, R2, R3, R4 and R5 have the definitions given in claim 1 ...
09/18/2007
RE39754Benzamide derivatives and pharmaceutical compositions containing same
The novel benzamide derivative represented by formula (1) and the novel anilide derivative represented by formula (13) of this invention has differentiation-inducing effect, and are, therefore, useful a therapeutic or improving agent for malignant tumors, autoimmune...
07/31/2007
7244853Dioxanes and uses thereof
In recognition of the need to develop novel therapeutic agents and efficient methods for the synthesis thereof, the present invention provides novel compounds of general formula (I): and pharmaceutically acceptable...
07/17/2007
7241319Dye composition comprising at least one polycationic direct dye, dyeing processes, uses, and multi-compartment devices
Disclosed herein is a dye composition for dyeing human keratin fibers, such as the hair, comprising a direct polycationic dye of formula (I) below: Col-Z-Col  (I) in which Col, which may be identical ...
07/10/2007
7193041Method for purification of recombinant proteins
Purification of poly-amino acid-tagged recombinant proteins has been improved by the use of a carboxymethylated aspartate ligand complexed with a third-block transition metal having an oxidation state of 2+ and a coordination number of 6. A method for syn...
03/20/2007
7186276Dye composition comprising at least one direct dye, dyeing processes, uses and multi-compartment devices
Disclosed herein is a dye composition for dyeing human keratin fibers, such as the hair, comprising a direct polycationic dye of formula (I) below: Col-Z-Col  (I) in which Col, which may be identical ...
03/06/2007
7169194Dye composition comprising at least one particular tricationic direct dye, dyeing process, use and multi-compartment devices
A dye composition for dyeing human keratin fibers, such as hair, comprising at least one direct tricationic dye of formula (I) below: Col—Z—Col   (I) wherein: Col, which may be identical or differ...
01/30/2007
7160513Batch reactor with injection system
An apparatus and method for injection of one or more chemical components into a reaction chamber are disclosed. The apparatus includes a reaction chamber for receiving one or more libraries in a fixed position relative to the chamber and configured to form a sealed ...
01/09/2007
7160852Polyalklbicylic derivatives
The compound according to the formula set forth below and the use of the compound in creating fragrances, and scents in items such as perfumes, colognes and personal care products is disclosed. ...
01/09/2007
7132554Therapeutic synergy of anti-cancer compounds
This invention relates to a synergistic therapeutic combination of anti-cancer compounds which comprises a) a taxane, and b) a substance that binds to the epidermal growth factor receptor (EGFR) and blocks the ability of epidermal growth factor (EGF) to intitiate re...
11/07/2006
71254281,3-Dihydroxybenzene derivatives and colorants containing said compounds
1,3-Dihydroxybenzene derivatives of general formula (I) or (Ia) or physiologically tolerated, water-soluble salts thereof wherein R′1 denotes a substituted pyridyl group, a pyrimidyl group, a group of formula (...
10/24/2006
7122574Treatment of hypertension
Polyphenol-containing compositions, for example procyanidins and derivatives thereof, and their use for treating hypertension are disclosed. Compositions may be used for human and veterinary use, and may be, for example, in a form of a food, a dietary supplement or ...
10/17/2006
7105685Cannabinol derivatives
The invention provides cannabinol derivatives and pharmaceutical preparations thereof. ...
09/12/2006
7094262Dye composition comprising at least one particular dissymetrical polycationic direct dye, dyeing process, use and multi-compartment devices
A dye composition for dyeing human keratin fibres, such as hair, comprising at least one dissymmetrical polycationic direct dye of formula (I) below: Col1-Z-Col2  (I) wherein: Col1 and Col2, wh...
08/22/2006
7094896Diaminothiazoles having antiproliferative activity
Disclosed are novel diaminothiazoles that are selective inhibitors of Cdk4. These compounds and their pharmaceutically acceptable salts and esters are anti-proliferative agents useful in the treatment or control of solid tumors, in particular breast, colon, lung and...
08/22/2006
7091336Lyophilized powder of lentinan and the process of preparation thereof
The present invention discloses an antineoplastic sterile lyophilized powder of lentinan and the process of preparation thereof. The lyophilized powder of lentinan is essentially consisted of 0.50–1.40 parts of lentinan and 50–140 parts of excipient for lyophili...
08/15/2006
6998417Compositions for, and methods of, treating atherosclerosis
Disclosed and claimed are cocoa extracts, compounds, combinations thereof and compositions containing the same, such as polyphenols or procyanidins, methods for preparing such extracts, compounds and compositions, as well as uses for them, especially a polymeric com...
02/14/2006
6974806Lipid-rich plaque inhibitors
The present invention provides a lipid-rich plaque regressing agent comprising a compound represented by Formula: in which ring A is a cyclic hydrocarbon or the like; ring B is a heterocyclic ring or the like; each of ...
12/13/2005
6962938Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)
The present application describes novel spiro-cyclic β-amino acid derivatives of formula I: or pharmaceutically acceptable salt forms thereof, wherein ring B is a 3-13 membered carbocycle or heterocycle, ring C forms ...
11/08/2005
6924276Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
The invention provides dicarboxylic acid-substituted heteroaryl derivatives of the formula G1-(C(R1)R2)n-Q1-B-Q2-(C(R3)R4)m-G2  I or...
08/02/2005
6887281N-heteroarylmethyl-p-phenylenediamine derivatives as well as oxidation dyeing agents containing these compounds
The new N-heteroarylmethyl-p-phenylenediamine derivatives have the general formula (I), Oxidation hair dyeing agents are described based on a combination of developing and coupling substance, which contain at least one...
05/03/2005
1      
 
Sign InRegister
Username  
Password   
forgot password?